
Acorda Therapeutics ACOR
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Acorda Therapeutics P/CF 2011-2025 | ACOR
P/CF Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.2 | -0.651 | -0.257 | -0.833 | -0.461 | 6.62 | 14.8 | -3.72 | 49.5 | -4.18 | 49 | 29.5 | 16.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.5 | -4.18 | 11.9 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-5.18 | $ 4.78 | -0.31 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
-7.59 | $ 3.03 | -0.49 % | $ 234 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 1.15 | -1.71 % | $ 6.27 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 209.39 | -1.61 % | $ 5 B | ||
|
Aptevo Therapeutics
APVO
|
-0.0374 | $ 0.6 | -35.8 % | $ 166 K | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.12 | 0.81 % | $ 7.51 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
BioVie
BIVI
|
-0.128 | $ 1.2 | -5.51 % | $ 1.77 M | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 0.22 | 24.46 % | $ 479 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 94.72 | -0.33 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 27.09 | 1.04 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
-209 | $ 9.6 | 1.27 % | $ 141 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
97.5 | $ 584.81 | -1.07 % | $ 44.3 B | ||
|
Cellectar Biosciences
CLRB
|
-1.37 | $ 2.53 | -8.33 % | $ 30.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.44 | -3.56 % | $ 15.3 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | $ 92.79 | 0.37 % | $ 96.9 B | ||
|
Catalyst Biosciences
CBIO
|
1.3 | $ 12.33 | -0.29 % | $ 812 M | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 9.1 | 1.0 % | $ 1.48 B | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 26.29 | -2.01 % | $ 1.69 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 11.07 | 2.45 % | $ 716 M | ||
|
Biogen
BIIB
|
6.73 | $ 176.45 | 0.07 % | $ 25.7 B | ||
|
Cerevel Therapeutics Holdings
CERE
|
-19.5 | - | - | $ 7.29 B |